Drugs by condition
Drugs approved for anxiety disorders
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
23
Still marketed, NDA or BLA
Drug classes
3
Novel drugs
8
New molecular entities and new biologics
In development
19
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for anxiety disorders.
- Duloxetine Hydrochloride (Duloxetine Hydrochloride) · Almatica Feb 27, 2026
- Escitalopram (Escitalopram Oxalate) · Almatica Aug 29, 2025
- Venlafaxine Besylate (Venlafaxine Besylate) · Almatica Jun 29, 2022
- Loreev Xr (Lorazepam) · Almatica Aug 27, 2021
- Drizalma Sprinkle (Duloxetine Hydrochloride) · Sun Pharm Jul 19, 2019
All approved drugs for anxiety disorders, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 274 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Benzodiazepine (7)
Monoamine Oxidase Inhibitor (1)
- Marplan Isocarboxazid · Lifsa Drugs · 1959
Class not listed in FDA's data (15)
- Paxil Paroxetine Hydrochloride · Apotex · 1992
- Zoloft Sertraline Hydrochloride · Viatris · 1991
- Nardil Phenelzine Sulfate · Parke Davis · 1961
- Duloxetine Hydrochloride Duloxetine Hydrochloride · Almatica · 2026
- Escitalopram Escitalopram Oxalate · Almatica · 2025
- Venlafaxine Besylate Venlafaxine Besylate · Almatica · 2022
- Drizalma Sprinkle Duloxetine Hydrochloride · Sun Pharm · 2019
- Brisdelle Paroxetine Mesylate · Legacy · 2013
- Beyaz Drospirenone, Ethinyl Estradiol, Levomefolate Calcium · Bayer Hlthcare · 2010
- Venlafaxine Hydrochloride Venlafaxine Hydrochloride · Osmotica Pharm US · 2008
- Yaz Drospirenone, Ethinyl Estradiol · Bayer Hlthcare · 2006
- Lexapro Escitalopram Oxalate · Abbvie · 2002
- Zoloft Sertraline Hydrochloride · Viatris · 1999
- Paxil Cr Paroxetine Hydrochloride · Apotex · 1999
- Effexor Xr Venlafaxine Hydrochloride · Upjohn · 1997
Drugs in development for anxiety disorders
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- SEP-363856UlotarontPhase 37 trials
Otsuka · Generalized Anxiety Disorder, Schizophrenia, Major Depressive Disorder
- ITI-1284JNJ-99245354Phase 36 trials
Intra-Cellular Therapies, Inc. · Generalized Anxiety Disorder, Agitation Associated With Alzheimer's Dementia, Psychotic Disorders
- DT120MM120, lysergide tartratePhase 34 trials
Definium Therapeutics US, Inc. · Generalized Anxiety Disorder, Major Depressive Disorder
- BuagafuranPhase 32 trials
Beijing Union Pharmaceutical Factory Ltd · Generalized Anxiety Disorder
- Buagafuran mimicPhase 32 trials
Beijing Union Pharmaceutical Factory Ltd · Generalized Anxiety Disorder
- FasedienolPhase 32 trials
VistaGen Therapeutics, Inc. · Social Anxiety Disorder, Social Anxiety Disorder (SAD)
- BNC210Phase 31 trial
Bionomics Limited · Social Anxiety Disorder
- Toludesvenlafaxine Hydrochloride Sustained-releasePhase 31 trial
Luye Pharma Group Ltd. · Generalized Anxiety Disorder
- VQW-765Phase 31 trial
Vanda Pharmaceuticals · Social Anxiety Disorder (SAD)
- ONO-1110Phase 25 trials
Ono Pharmaceutical Co., Ltd. · Fibromyalgia, Social Anxiety Disorder (SAD), Major Depressive Disorder (MDD
- ABBV-932Phase 23 trials
AbbVie · Bipolar I or II Disorder, Generalized Anxiety Disorder (GAD), Bipolar I Disorder
- ENX-102ENX-102 -dose, ENX-102 mid-dosePhase 23 trials
Engrail Therapeutics INC · General Anxiety Disorder, Social Anxiety Disorder (SAD), Generalized Anxiety Disorder
- RE104Phase 23 trials
Reunion Neuroscience Inc · Adjustment Disorder, Generalized Anxiety Disorder, Postpartum Depression
- AFA-281Phase 22 trials
Afasci Inc · Alcohol Abuse, Alcohol Abuse/addiction, Anxiety
- CYB004Phase 21 trial
Cybin IRL Limited · Generalized Anxiety Disorder
- EMP-01Phase 21 trial
atai Therapeutics, Inc. · Social Anxiety Disorder
- NTX-1472Phase 21 trial
Newleos Therapeutics, Inc. · Social Anxiety Disorder (SAD)
- RGH-202Phase 21 trial
Gedeon Richter Plc. · Social Anxiety Disorder
- SYT-510Phase 21 trial
Synendos Therapeutics AG · Generalized Anxiety Disorder
2 discontinued brand-name drugs whose label still names it
More on anxiety disorders: recruiting trials · published research
Related in psychiatry: Depression (major depressive disorder) · Schizophrenia · Bipolar disorder · ADHD · Insomnia · Opioid use disorder · Alcohol dependence · Smoking cessation · PTSD · Postpartum depression
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.